AU2002215180A1 - Beta-lactam antibiotic-polysaccharide complex - Google Patents

Beta-lactam antibiotic-polysaccharide complex

Info

Publication number
AU2002215180A1
AU2002215180A1 AU2002215180A AU1518002A AU2002215180A1 AU 2002215180 A1 AU2002215180 A1 AU 2002215180A1 AU 2002215180 A AU2002215180 A AU 2002215180A AU 1518002 A AU1518002 A AU 1518002A AU 2002215180 A1 AU2002215180 A1 AU 2002215180A1
Authority
AU
Australia
Prior art keywords
beta
lactam antibiotic
polysaccharide complex
polysaccharide
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002215180A
Inventor
Prasanta Kumar Chakrabarti
Canakapalli Bhaktavatsala Rao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orchid Pharma Ltd
Original Assignee
Orchid Chemicals and Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Chemicals and Pharmaceuticals Ltd filed Critical Orchid Chemicals and Pharmaceuticals Ltd
Publication of AU2002215180A1 publication Critical patent/AU2002215180A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AU2002215180A 2000-10-12 2001-10-11 Beta-lactam antibiotic-polysaccharide complex Abandoned AU2002215180A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN730/MAS/1999 2000-10-12
IN729/MAS/1999 2000-10-12
IN730MA1999 2000-10-12
IN729MA1999 2000-10-12
PCT/IN2001/000179 WO2002030469A2 (en) 2000-10-12 2001-10-11 Beta-lactam antibiotic-polysaccharide complex

Publications (1)

Publication Number Publication Date
AU2002215180A1 true AU2002215180A1 (en) 2002-04-22

Family

ID=26324828

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002215180A Abandoned AU2002215180A1 (en) 2000-10-12 2001-10-11 Beta-lactam antibiotic-polysaccharide complex

Country Status (2)

Country Link
AU (1) AU2002215180A1 (en)
WO (1) WO2002030469A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2844791C (en) * 2011-08-15 2016-12-06 John J. Matta Water soluble antimicrobial composition
US8815952B1 (en) 2013-03-15 2014-08-26 Carnell & Herzog, LLC Chlorhexadine antiseptic
CN104382864A (en) * 2014-08-29 2015-03-04 四川制药制剂有限公司 Processing technology of ceftriaxone sodium for injection
CN106279208A (en) * 2016-08-15 2017-01-04 陕西顿斯制药有限公司 A kind of cefotaxime sodium compound utilizing fluid mechanics principle to prepare and preparation thereof
CN113842365B (en) * 2021-10-28 2022-10-28 海南海灵化学制药有限公司 Preparation process of cefazolin sodium for injection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0083367A1 (en) * 1981-07-02 1983-07-13 WALTON, Alan G. Glycosaminoglycan drug complexes
DK0531497T3 (en) * 1991-04-02 1998-03-23 Biotech Australia Pty Ltd Oral administration systems for microparticles
AU4572097A (en) * 1996-10-15 1998-05-11 Ebara Corporation Bioactive polymer product
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
IT1312110B1 (en) * 1999-05-18 2002-04-04 Istituto Biochimico Pavese Pha NATURAL ANTIBIOTIC-POLYESACCHARIDIC POLYMER ADDUCTS
KR100858945B1 (en) * 2000-06-21 2008-09-17 큐비스트 파마슈티컬즈 인코포레이티드 Compositions and methods to improve the oral absorption of antimicrobial agents

Also Published As

Publication number Publication date
WO2002030469A3 (en) 2003-02-27
WO2002030469A2 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
AU6419701A (en) Electropancreatography
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2002211620A1 (en) Autoanastomosis
AU2001258349A1 (en) Bisacylguanidine
AU2001296577A1 (en) Chlorophyllases
AU2001279754A1 (en) Indoloquinazolinones
AU2001257490A1 (en) Improved beta-lactam antibiotics
AU2002211128A1 (en) Step-bike
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en) Ski-snowboard
AU2001293852A1 (en) Sulfonylguanidine
AU2001258924A1 (en) Microsatellite-aflp
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2001281921A1 (en) Bdellosomes
AU2001246864A1 (en) Hypotensors
AU2001291876A1 (en) Triazolo-epothilones
AU2002214354A1 (en) Neck-phone
AU2002215180A1 (en) Beta-lactam antibiotic-polysaccharide complex
AU4620300A (en) Can
AU2001260192A1 (en) Glycinamides